ANYO Labs
Anyo Labs is a pharmaceutical drug discovery company founded in 2022, aiming to transform drug discovery into a precise engineering discipline. By leveraging advanced models and logical decision-making, they engineer life-saving treatments tailored to individual needs. Their core technology, developed from research at the University of Gothenburg and Chalmers Technical University, focuses on Intelligent Drug Engineering. Anyo Labs offers a proprietary in silico AI-driven screening platform called Anyo Technology, which enables rapid and cost-efficient exploration of chemical space for hit identification, hit-to-lead optimization, and lead optimization. They work with partners on drug engineering projects and research collaborations, seeking to take new chemical entities to validation faster. The company has been recognized with the TOP 100 award by Vetenskapsrådet - IVA.
ANYO Labs
Anyo Labs is a pharmaceutical drug discovery company founded in 2022, aiming to transform drug discovery into a precise engineering discipline. By leveraging advanced models and logical decision-making, they engineer life-saving treatments tailored to individual needs. Their core technology, developed from research at the University of Gothenburg and Chalmers Technical University, focuses on Intelligent Drug Engineering. Anyo Labs offers a proprietary in silico AI-driven screening platform called Anyo Technology, which enables rapid and cost-efficient exploration of chemical space for hit identification, hit-to-lead optimization, and lead optimization. They work with partners on drug engineering projects and research collaborations, seeking to take new chemical entities to validation faster. The company has been recognized with the TOP 100 award by Vetenskapsrådet - IVA.